New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
Masimo Corporation (MASI)
Last masimo corporation earnings: 4/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
masimo.com/about-masimo/investors
Company Research
Source: Business Wire
Researchers Found That Noninvasive, Continuous PVi Was Equally Effective in Guiding Fluid Management As Stroke Volume Variation (SVV), an Invasive Method Requiring an Arterial Line NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated the use of noninvasive, continuous Masimo PVi®, as part of goal-directed fluid therapy (GDFT), to guide intraoperative fluid administration during neurosurgery – the first study to evaluate PVi in this surgical scenario – by comparing it to a parameter obtained invasively, stroke volume variation (SVV). The researchers concluded that “PVi and SVV are equally effective for guiding intraoperative goal-directed fluid therapy in adult neurosurgical patients scheduled for elective craniotomy for supratentorial brain tumors. However, PVi, being a noni
Show less
Read more
Impact Snapshot
Event Time:
MASI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MASI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MASI alerts
High impacting Masimo Corporation news events
Weekly update
A roundup of the hottest topics
MASI
News
- Global Neonatal Intensive Care Market Report 2024-2030: North America Leads, Demand for Neonatal Incubators Surges as Neonatal Intensive Care Evolves [Yahoo! Finance]Yahoo! Finance
- Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7Business Wire
- Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Reasons Why You Should Retain Masimo (MASI) Stock for Now [Yahoo! Finance]Yahoo! Finance
- Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in ChileBusiness Wire
MASI
Earnings
- 2/27/24 - Beat
MASI
Sec Filings
- 4/2/24 - Form DEFA14A
- 4/1/24 - Form DEFA14A
- 3/27/24 - Form SC
- MASI's page on the SEC website